Comparison Kura Oncology (KURA) with Competitors
Kura Oncology (KURA) industry is Biotechnology.
Operating Margin
KURA-431.50%
Industry-2055.25%
Upside+1623.75%
Debt-to-Equity
KURA9.04%
Industry28.27%
Upside-68.03%
Free Cash Flow Yield
KURA-8.40%
Industry-1.75%
Upside-6.65%
P/E
KURA-3.37
Industry-20.52
Upside+1714.70%
P/S
KURA13.93
Industry10.01
Upside+39.11%
P/B
KURA9.25
Industry5.15
Upside+79.72%